Zong Hai Li
Chief Executive Officer bij CARSGEN THERAPEUTICS HOLDINGS LIMITED
Vermogen: 164 M $ op 30-04-2024
Profiel
Zong Hai Li richtte CARsgen Therapeutics Holdings Ltd. en CARsgen Therapeutics Co. Ltd. op. Hij is voorzitter, Chief Executive & Scientific Officer bij CARsgen Therapeutics Holdings Ltd. en President & Chief Executive Officer voor CARsgen Therapeutics Co. Ltd. Dr. Li was voorheen professor aan het Shanghai Cancer Institute en professor aan het Renji Hospital. Hij behaalde een bachelor en een doctoraat aan de Central South University van het Xiangya Hospital.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-04-2024 | 216 387 730 ( 37.59% ) | 164 M $ | 30-04-2024 |
Actieve functies van Zong Hai Li
| Bedrijven | Functie | Begin |
|---|---|---|
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Chief Executive Officer | 01-02-2021 |
CARsgen Therapeutics Co. Ltd.
 CARsgen Therapeutics Co. Ltd. BiotechnologyHealth Technology CARsgen Therapeutics Co., Ltd. develops an immunotherapy cancer treatment. It develops a novel cell-based immunotherapy using T-cells carrying chimeric antigen receptor technology for cancer treatment. The company was founded by ZongHai Li in 2014 and is headquartered in Shanghai, China. | Chief Executive Officer | 30-10-2014 |
Eerdere bekende functies van Zong Hai Li
| Bedrijven | Functie | Einde |
|---|---|---|
Guilin Pavay Gene Pharmaceutical Co. Ltd.
 Guilin Pavay Gene Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hua Han Health Industry Holdings Ltd., Guilin Pavay Gene Pharmaceutical Co. Ltd. is a private company that manufactures and distributes pharmaceutical products. The company is based in Guilin, China. | Corporate Officer/Principal | 01-04-2002 |
Renji Hospital
 Renji Hospital Hospital/Nursing ManagementHealth Services Renji Hospital, located in Huangpu, China, was built in 1844 and has a history of over 170 years. It is a comprehensive 3A hospital with a complete range of disciplines, integrating medical treatment, teaching, and scientific research. Renji Hospital was the first medical institution in China to carry out clinical and scientific research on assisted reproductive technology and has become the quality control center for assisted reproductive technology since 2018. The hospital has five areas in total and has a timeline of development process. | Corporate Officer/Principal | - |
| The Shanghai Cancer Institute | Corporate Officer/Principal | - |
Opleiding van Zong Hai Li
| Xiangya Hospital Central South University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Guilin Pavay Gene Pharmaceutical Co. Ltd.
Guilin Pavay Gene Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hua Han Health Industry Holdings Ltd., Guilin Pavay Gene Pharmaceutical Co. Ltd. is a private company that manufactures and distributes pharmaceutical products. The company is based in Guilin, China. | Health Technology |
| The Shanghai Cancer Institute | |
CARsgen Therapeutics Co. Ltd.
CARsgen Therapeutics Co. Ltd. BiotechnologyHealth Technology CARsgen Therapeutics Co., Ltd. develops an immunotherapy cancer treatment. It develops a novel cell-based immunotherapy using T-cells carrying chimeric antigen receptor technology for cancer treatment. The company was founded by ZongHai Li in 2014 and is headquartered in Shanghai, China. | Health Technology |
Renji Hospital
Renji Hospital Hospital/Nursing ManagementHealth Services Renji Hospital, located in Huangpu, China, was built in 1844 and has a history of over 170 years. It is a comprehensive 3A hospital with a complete range of disciplines, integrating medical treatment, teaching, and scientific research. Renji Hospital was the first medical institution in China to carry out clinical and scientific research on assisted reproductive technology and has become the quality control center for assisted reproductive technology since 2018. The hospital has five areas in total and has a timeline of development process. | Health Services |
